Recent advancements in 18F-FDG PET/CT for the diagnosis, staging, and treatment management of HIV-related lymphoma

被引：0

作者：

Soufi, Ghazaleh Jamalipour ^{[1
]}

Hekmatnia, Ali ^{[1
]}

Hekmatnia, Farzaneh ^{[2
]}

Zarei, Andrew Parviz ^{[3
]}

Shafieyoon, Shamim ^{[1
]}

Azizollahi, Sara ^{[1
]}

Hashemi, Mohamad Ghazanfari ^{[4
]}

Riahi, Farshad ^{[1
]}

机构：

[1] Isfahan Univ Med Sci, Dept Radiol, Esfahan, Iran

[2] St George Hosp, Dept Radiol, London, England

[3] Princes Alexandra Hosp, Dept Med, London, England

[4] Univ Tehran Med Sci, Canc Inst, Dept Radiol, Tehran, Iran

来源：

AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 14卷 / 02期

关键词：

Human immunodeficiency virus; diffuse large B-cell lymphoma; Burkitt's lymphoma; Hodgkin's lymphoma; (18) F-fluorodeoxy- glucose positron emission tomography/computed tomography; POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKIN-LYMPHOMA; RESPONSE ASSESSMENT; FDG-PET/CT; DIFFERENTIAL-DIAGNOSIS; F-18-FDG PET/CT; CNS LESIONS; FOLLOW-UP; THERAPY;

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Infection with the Human Immunodeficiency Virus (HIV) is one of the most pressing issues facing public health on a worldwide scale. Currently, HIV-related lymphoma is the most common cause of death among people living with HIV, and warrants more attention. The unique challenges associated with HIV-related lymphoma management derive from the underlying HIV infection and its immunosuppressive effects. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has gained significant prominence in the past few years as a valuable diagnostic and therapeutic instrument for the treatment of HIV-related lymphoma. This review will start with an overview of the subtypes, risk factors, and therapeutic choices for individuals with HIV-related lymphoma. We will then briefly discuss the current application of F-18-FDG PET/CT in the medical management of HIV-related lymphoma patients, followed by the initial staging of the disease, the evaluation of therapeutic response, the prediction of prognostic outcomes, the decision-making process for radiotherapy guided by PET findings, and the distinguishing of various diagnoses.

引用

页码：97 / 109

页数：13

共 50 条

[1] Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
Andre, Marc P. E.
Girinsky, Theodore
Federico, Massimo
Reman, Oumedaly
Fortpied, Catherine
Gotti, Manuel
Casasnovas, Olivier
Brice, Pauline
van der Maazen, Richard
Re, Alessandro
Edeline, Veronique
Ferme, Christophe
van Imhoff, Gustaaf
Merli, Francesco
Bouabdallah, Reda
Sebban, Catherine
Specht, Lena
Stamatoullas, Aspasia
Delarue, Richard
Fiaccadori, Valeria
Bellei, Monica
Raveloarivahy, Tiana
Versari, Annibale
Hutchings, Martin
Meignan, Michel
Raemaekers, John
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1786 - +
[2] Bahrami M, 2023, AM J NUCL MED MOLEC, V13, P127
[3] HIV/AIDS Associated Lymphoma: Review
Berhan, Ayenew
Bayleyegn, Biruk
Getaneh, Zegeye
[J]. BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 31 - 45
[4] FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, Ronald
Delgado-Bolton, Roberto
Oyen, Wim J. G.
Giammarile, Francesco
Tatsch, Klaus
Eschner, Wolfgang
Verzijlbergen, Fred J.
Barrington, Sally F.
Pike, Lucy C.
Weber, Wolfgang A.
Stroobants, Sigrid
Delbeke, Dominique
Donohoe, Kevin J.
Holbrook, Scott
Graham, Michael M.
Testanera, Giorgio
Hoekstra, Otto S.
Zijlstra, Josee
Visser, Eric
Hoekstra, Corneline J.
Pruim, Jan
Willemsen, Antoon
Arends, Bertjan
Kotzerke, Joerg
Bockisch, Andreas
Beyer, Thomas
Chiti, Arturo
Krause, Bernd J.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 328 - 354
[5] Clinical features and 18F-FDG PET/CT for distinguishing of malignant lymphoma from inflammatory lymphadenopathy in HIV-infected patients
Chen, Donghe
Zhu, Yunqi
Chen, Yunbo
Zhu, Danhua
Liu, Zhengfeng
Li, Tiancheng
Liu, Yinuo
Zhao, Kui
Su, Xinhui
Li, Lanjuan
[J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
[6] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Cheson, Bruce D.
Fisher, Richard I.
Barrington, Sally F.
Cavalli, Franco
Schwartz, Lawrence H.
Zucca, Emanuele
Lister, T. Andrew
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3059 - +
[7] Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
Danilov, Alexey V.
Li, Hongli
Press, Oliver W.
Shapira, Ilan
Swinnen, Lode J.
Noy, Ariela
Reid, Erin
Smith, Sonali M.
Friedberg, Jonathan W.
[J]. LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 461 - 465
[8] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Eisenhauer, E. A.
Therasse, P.
Bogaerts, J.
Schwartz, L. H.
Sargent, D.
Ford, R.
Dancey, J.
Arbuck, S.
Gwyther, S.
Mooney, M.
Rubinstein, L.
Shankar, L.
Dodd, L.
Kaplan, R.
Lacombe, D.
Verweij, J.
[J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247
[9] FDG-PET/CT in the management of lymphomas: current status and future directions
El-Galaly, T. C.
Villa, D.
Gormsen, L. C.
Baech, J.
Lo, A.
Cheah, C. Y.
[J]. JOURNAL OF INTERNAL MEDICINE, 2018, 284 (04) : 358 - 376
[10] Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs
El-Galaly, Tarec Christoffer
Mylam, Karen Juul
Brown, Peter
Specht, Lena
Christiansen, Ilse
Munksgaard, Lars
Johnsen, Hans Erik
Loft, Annika
Bukh, Anne
Iyer, Victor
Nielsen, Anne Lerberg
Hutchings, Martin
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (06): : 931 - 936

← 1 2 3 4 5 →